| NDC Code | 17312-171-14 |
|---|
| Package Description | 1 BOTTLE in 1 PACKAGE (17312-171-14) / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE |
|---|
| Product NDC | 17312-171 |
|---|
| Product Type Name | HUMAN OTC DRUG |
|---|
| Proprietary Name | Fibromyalgia Relief |
|---|
| Non-Proprietary Name | Bryonia Alba Root - Causticum - Loeselia Mexicana Whole - Magnesium Phosphate - Pulsatilla Vulgaris - Toxicodendron Pubescens Leaf - Valerian |
|---|
| Dosage Form | TABLET, ORALLY DISINTEGRATING |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20200528 |
|---|
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
|---|
| Manufacturer | TRP Company |
|---|
| Substance Name | BRYONIA ALBA ROOT; CAUSTICUM; LOESELIA MEXICANA WHOLE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PULSATILLA VULGARIS; TOXICODENDRON PUBESCENS LEAF |
|---|
| Strength | 6; 6; 6; 6; 6; 6 |
|---|
| Strength Unit | [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1 |
|---|
| Pharmacy Classes | Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] |
|---|